Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper B Andersen

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Journal of Hepatology|December 4, 2020
Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypesChirag Nepal, Bin Zhu, Colm J O'Rourke, et al.
Gastroenterology|November 9, 2017
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in CholangiocarcinomaAndrea Lampis, Pietro Carotenuto, Georgios Vlachogiannis, et al.
Hepatology (Baltimore, Md.)|January 14, 2022
Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipidsMikel Ruiz de Gauna, Francesca Biancaniello, Francisco González-Romero, et al.
Cells|March 19, 2020
Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease DiagnosisAinhoa Lapitz, Ander Arbelaiz, Colm J O'Rourke, et al.
Hepatology (Baltimore, Md.)|February 11, 2025
Targeting protein hyper-SUMOylation halts cholangiocarcinoma progression by impairing cancer cell viability and tumor-stroma cross talkPaula Olaizola, Irene Olaizola, Marta Fernandez de Ara, et al.
NPJ Precision Oncology|January 27, 2026
Multimodal single-cell profiling reveals crosstalk between macrophages and stromal cells in poor prognostic cholangiocarcinoma patientsLara Heij, Sikander Hayat, Konrad Reichel, et al.
Gut|September 27, 2023
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapyColm J O'Rourke, Massimiliano Salati, Colin Rae, et al.
Nature Reviews. Gastroenterology & Hepatology|July 2, 2020
Cholangiocarcinoma 2020: the next horizon in mechanisms and managementJesus M Banales, Jose J G Marin, Angela Lamarca, et al.
Cancer Cell|June 27, 2017
Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and CholangiocarcinomaJittiporn Chaisaingmongkol, Anuradha Budhu, Hien Dang, et al.
Journal of Hepatology|March 3, 2023
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinomaAinhoa Lapitz, Mikel Azkargorta, Piotr Milkiewicz, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Journal of Hepatology|December 4, 2020
Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypesChirag Nepal, Bin Zhu, Colm J O'Rourke, et al.
Gastroenterology|November 9, 2017
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in CholangiocarcinomaAndrea Lampis, Pietro Carotenuto, Georgios Vlachogiannis, et al.
Hepatology (Baltimore, Md.)|January 14, 2022
Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipidsMikel Ruiz de Gauna, Francesca Biancaniello, Francisco González-Romero, et al.
Cells|March 19, 2020
Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease DiagnosisAinhoa Lapitz, Ander Arbelaiz, Colm J O'Rourke, et al.
Hepatology (Baltimore, Md.)|February 11, 2025
Targeting protein hyper-SUMOylation halts cholangiocarcinoma progression by impairing cancer cell viability and tumor-stroma cross talkPaula Olaizola, Irene Olaizola, Marta Fernandez de Ara, et al.
NPJ Precision Oncology|January 27, 2026
Multimodal single-cell profiling reveals crosstalk between macrophages and stromal cells in poor prognostic cholangiocarcinoma patientsLara Heij, Sikander Hayat, Konrad Reichel, et al.
Gut|September 27, 2023
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapyColm J O'Rourke, Massimiliano Salati, Colin Rae, et al.
Nature Reviews. Gastroenterology & Hepatology|July 2, 2020
Cholangiocarcinoma 2020: the next horizon in mechanisms and managementJesus M Banales, Jose J G Marin, Angela Lamarca, et al.
Cancer Cell|June 27, 2017
Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and CholangiocarcinomaJittiporn Chaisaingmongkol, Anuradha Budhu, Hien Dang, et al.
Journal of Hepatology|March 3, 2023
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinomaAinhoa Lapitz, Mikel Azkargorta, Piotr Milkiewicz, et al.
Pageof 15